Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAM: Anticholinergic vs Mirabegron in Overactive Bladder
NCT07711808Phase 4Not yet recruiting
- Sponsor
- University of Porto
- Start
- Jul 2026
- Primary completion
- Jul 2027
01
Overview
A Phase 4 trial of solifenacin, mirabegron in overactive bladder (OAB), sponsored by University of Porto. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
solifenacinmirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT07711808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711808.